Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
54.29
-0.32 (-0.59%)
At close: Aug 13, 2026, 4:00 PM EDT
54.40
+0.11 (0.20%)
Pre-market: Aug 14, 2026, 8:04 AM EDT
Tempus AI Employees
Tempus AI had 3,800 employees as of December 31, 2025. The number of employees increased by 1,400 or 58.33% compared to the previous year.
Employees
3,800
Change (1Y)
1,400
Growth (1Y)
58.33%
Revenue / Employee
$376,847
Profits / Employee
-$66,954
Market Cap
9.80B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3,800 | 1,400 | 58.33% |
| Dec 31, 2024 | 2,400 | 100 | 4.35% |
| Dec 31, 2023 | 2,300 | 348 | 17.83% |
| Dec 31, 2022 | 1,952 | 385 | 24.57% |
| Dec 31, 2021 | 1,567 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BrightSpring Health Services | 23,500 |
| Veeva Systems | 7,928 |
| Omnicell | 3,485 |
| HealthEquity | 2,814 |
| Waystar Holding | 1,700 |
| Privia Health Group | 1,226 |
| 10x Genomics | 1,178 |
| Omada Health | 946 |
TEM News
- 7 days ago - Tempus AI added to CellCarta’s CDx commercialization lab network - TheFly
- 7 days ago - CellCarta Adds Tempus to CDx Commercialization Lab Network - PRNewsWire
- 9 days ago - Personalis says not providing guidance or conducting earnings call - TheFly
- 9 days ago - Tempus AI announces study results of PRISM2 - TheFly
- 9 days ago - Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications - Business Wire
- 10 days ago - Tempus AI price target lowered to $56 from $58 at Piper Sandler - TheFly
- 10 days ago - Tempus AI price target lowered to $70 from $80 at BTIG - TheFly
- 10 days ago - Tempus AI price target lowered to $56 from $64 at H.C. Wainwright - TheFly